AMEX · MGLD

The Marygold Companies, Inc.

$1.15 +$0.03 (+2.68%) 1D Market open

Key Metrics

$48.25M
Market cap
P/E · TTM
$29.01M
Revenue · TTM
−$2.19M
Net income
EPS · TTM $-0.05
Dividend yield
Free cash flow −$2.98M
Beta · 1Y -0.26
EBITDA · TTM −$2.19M
Gross margin 78.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 20
    The stock moved +29.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 20
  • Mar 18
    From its Feb 2 high, the share price fell 25%.

    Peak close $1.30 on Feb 2; trough close $0.97 on Mar 18. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -25%
  • Feb 17
    The stock moved +22.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$48.25M
Enterprise value
Shares outstanding43.1M
52-wk range$0.64 – $1.38
Avg volume · 20D156.5K
Net cash
Book value / share$0.53
IndustryFinance Services
ExchangeAMEX
About The Marygold Companies, Inc.
IPO dateDec 5, 1996
Employees116

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.66
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 78.3%
Operating -9.0%
Net -7.5%
FCF -10.3%
ROE / ROIC -8.8% · -17.9%

Financial Health

Current ratio4.21
Quick ratio3.94
Debt / equity
Debt / EBITDA
Net cash
Working capital$12.56M

Cash Flow · TTM

Operating CF −$2.95M
Capex −$30.00K
Free cash flow −$2.98M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

7.2
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings